Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1
Phase 3
Completed
- Conditions
- Heroin DependenceSubstance-Related Disorders
- First Posted Date
- 2001-04-18
- Last Posted Date
- 2017-01-16
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00015171
- Locations
- ๐บ๐ธ
New York MDRU, New York, New York, United States
Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 2001-04-18
- Last Posted Date
- 2017-01-16
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 20
- Registration Number
- NCT00015054
- Locations
- ๐บ๐ธ
Cincinnati MDRU, Cincinnati, Ohio, United States
Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2
Phase 1
Completed
- Conditions
- Substance-Related DisordersOpioid-Related Disorders
- First Posted Date
- 2001-04-18
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00015041
- Locations
- ๐บ๐ธ
Cincinnati MDRU, Cincinnati, Ohio, United States
Tiagabine, Sertraline, or Donepezil for the Treatment of Cocaine Dependence - 9
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 2001-04-18
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00015132
- Locations
- ๐บ๐ธ
Cincinnati MDRU, Cincinnati, Ohio, United States
Naltrexone in Treatment of Cocaine Dependence - 5
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 2001-04-18
- Last Posted Date
- 2017-01-16
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00015080
- Locations
- ๐บ๐ธ
Cincinnati MDRU, Cincinnati, Ohio, United States
Cocaine-Methylphendidate Interaction Study - 4
Phase 1
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 2001-04-18
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 8
- Registration Number
- NCT00015067
- Locations
- ๐บ๐ธ
Cincinnati MDRU, Cincinnati, Ohio, United States
Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14
Phase 4
Completed
- Conditions
- Opioid DependenceSubstance-Related Disorders
- Interventions
- First Posted Date
- 2001-04-18
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 582
- Registration Number
- NCT00015340
- Locations
- ๐บ๐ธ
VA PUget Sound Helath Care System, Seattle, Washington, United States
๐บ๐ธVA Medical Center, Hines, Illinois, United States
๐บ๐ธUniversity of California, Los Angeles, California, United States
Modeling Impaired Judgement in Cocaine Abusers - 6
Phase 4
Completed
- Conditions
- Cocaine-Related DisordersSubstance-Related Disorders
- First Posted Date
- 2001-04-18
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00015236
- Locations
- ๐บ๐ธ
New York MDRU, New York, New York, United States
Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5
Phase 2
Completed
- Conditions
- Substance-Related DisordersCocaine-Related Disorders
- First Posted Date
- 2001-04-18
- Last Posted Date
- 2017-01-16
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00015223
- Locations
- ๐บ๐ธ
Cincinnati MDRU, Cincinnati, Ohio, United States
Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1
Phase 2
Completed
- Conditions
- Opioid-Related DisordersSubstance-Related Disorders
- First Posted Date
- 2001-04-18
- Last Posted Date
- 2017-01-16
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00015028
- Locations
- ๐บ๐ธ
Cincinnati MDRU, Cincinnati, Ohio, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath